DNA
Ginkgo Bioworks Holdings
$6.78
−$0.01 (−0.15%)Sep 10, 2026
Key metrics
The numbers that frame DNA today
- Market cap
- $456.57M
- P/E (TTM)
- -1.6
- EV / FCF
- -4.0
- Gross margin
- 77.7%
- EV / Sales
- 6.2
- ROIC
- -24.2%
- Div yield
- 0%
- Debt / equity
- 1.0
- 52wk Low
- $5.37
- 52wk High
- $17.58
Growth
Revenue and earnings trend for DNA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DNA
Is Ginkgo Bioworks Holdings a good buy?
No. Ginkgo Bioworks Holdings has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Ginkgo Bioworks Holdings is selling at a very high price.
What is the market capitalization of DNA?
Ginkgo Bioworks Holdings's market capitalization is $456.57M.
What is the P/E ratio for DNA stock?
Ginkgo Bioworks Holdings's current P/E ratio is -1.6.
What is the 52-week high for DNA stock?
The 52-week high for Ginkgo Bioworks Holdings is $17.58. The current close of $6.78 is 61.4% below that high.
What is the 52-week low for DNA stock?
The 52-week low for Ginkgo Bioworks Holdings is $5.37. The current close of $6.78 is 26.3% above that low.
Does DNA stock pay dividends?
Ginkgo Bioworks Holdings does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for DNA?
Ginkgo Bioworks Holdings's Debt / Equity ratio is 0.96.